Record NNP B-NP O
date NN I-NP O
: : O O
2066-09-16 CD O B-DATE
51 CD B-NP B-AGE
yo NNP I-NP O
F NNP I-NP O
with IN B-PP O
HTN NNP B-NP O
, , O O
DM NNP B-NP O
, , O O
CAD NNP B-NP O
, , O O
gastritis NN B-NP O
, , O O
depression NN B-NP O
, , O O
s/p VBD B-VP O
CVA NNP B-NP O
returns NNS I-NP O
for IN B-PP O
f/u NN B-NP O
. . O O
Pt JJ B-NP O
reports NNS I-NP O
that IN B-SBAR O
she PRP B-NP O
has VBZ B-VP O
not RB I-VP O
been VBN I-VP O
taking VBG I-VP O
any DT B-NP O
medications NNS I-NP O
for IN B-PP O
one CD B-NP O
month NN I-NP O
. . O O
She PRP B-NP O
left VBD B-VP O
for IN B-PP O
Poland NNP B-NP B-COUNTRY
for IN B-PP O
two CD B-NP O
months NNS I-NP O
and CC O O
ran VBD B-VP O
out IN B-PP O
of IN B-PP O
medications NNS B-NP O
. . O O
Pt NNP B-NP O
reprots VBZ B-VP O
her PRP$ B-NP O
sugars NNS I-NP O
have VBP B-VP O
been VBN I-VP O
in IN B-PP O
the DT B-NP O
400-500 CD I-NP O
. . O O
Pt JJ B-NP O
reports NNS I-NP O
numbness NN I-NP O
of IN B-PP O
both DT B-NP O
feet NNS I-NP O
, , O O
and CC O O
the DT B-NP O
loss NN I-NP O
of IN B-PP O
her PRP$ B-NP O
her PRP$ I-NP O
toe NN I-NP O
nails NNS I-NP O
. . O O
Very RB B-ADJP O
noncompliant JJ I-ADJP O
with IN B-PP O
meds NNS B-NP O
and CC I-NP O
appts NNS I-NP O
Also RB B-ADVP O
c/o JJ B-NP O
thick JJ I-NP O
, , I-NP O
cottage NN I-NP O
cheesy NN I-NP O
vaginal JJ I-NP O
d/c NN I-NP O
and CC I-NP O
itch NN I-NP O
. . O O
Problems NNS B-NP O
HTN . O O
DM . O O
CAD NN B-NP O
: : O O
-EKG JJ B-ADJP O
with IN B-PP O
LVH NNP B-NP O
and CC I-NP O
repol NN I-NP O
abnlity NN I-NP O
. . O O
-Stress NN B-NP O
echo NN I-NP O
( -LRB- I-NP O
) -RRB- I-NP O
Limited NNP I-NP O
, , O O
only RB B-NP O
able JJ I-NP O
to TO B-VP O
walk VB I-VP O
0'47" CD B-NP O
. . B-PP O
MHR NNP B-NP O
122 CD I-NP O
( -LRB- I-NP O
72 CD I-NP O
%predicted VBN I-NP O
) -RRB- I-NP O
, , O O
BP NNP B-NP O
230/100 CD I-NP O
. . O O
Stopped NNP B-NP O
2/2 CD I-NP O
dizziness NN I-NP O
, , O O
SOB NNP B-NP O
and CC O O
SSCP. NNP B-NP O
EKG NNP I-NP O
shwed VBD B-VP O
1 CD B-NP O
mm CD I-NP O
ST NNP I-NP O
depressions NNS I-NP O
in IN B-PP O
II NNP B-NP O
, , O O
III NNP B-NP O
, , O O
F NNP B-NP O
, , O O
V5-6 NNP B-NP O
. . I-NP O
Read NNP I-NP O
as IN B-PP O
c/w JJ B-ADJP O
but CC O O
not RB B-ADJP O
diagnostic JJ I-ADJP O
of IN B-PP O
ischemia NN B-NP O
. . O O
Echo NNP B-NP O
showed VBD B-VP O
baseline NN B-NP O
EF NN I-NP O
of IN B-PP O
60 CD B-NP O
% NN I-NP O
with IN B-PP O
no DT B-NP O
RWMA. NNP I-NP O
After IN B-PP O
exercise NN B-NP O
there EX B-NP O
was VBD B-VP O
minor JJ B-NP O
nonspecific JJ I-NP O
inferoposterior JJ I-NP O
WMA. NNP I-NP O
Read NNP I-NP O
as IN B-PP O
no DT B-NP O
evidence NN I-NP O
of IN B-PP O
inducible JJ B-NP O
ischenia NN I-NP O
( -LRB- O O
but CC O O
low JJ B-NP O
sensitivity NN I-NP O
2/2 VBD B-VP O
low JJ B-NP O
MHR NN I-NP O
) -RRB- O O
HX NN B-NP O
OF IN B-PP O
GASTRITIS NNP B-NP O
BY NNP I-NP O
UGIS NNP I-NP O
H NNP I-NP O
PYLORI NNP I-NP O
+ . O O
S/P NNP B-NP O
TAH NNP I-NP O
2/2 CD I-NP O
FIBROIDS NNS I-NP O
OA NN B-NP O
Depression NN B-NP O
Asthma . O O
s/p NN B-NP O
CVA NNS I-NP O
Medications NNS B-NP O
Humulin NNP B-NP O
70/30 CD I-NP O
60 CD I-NP O
UNITS NNP I-NP O
qpm NN I-NP O
x NN I-NP O
30 CD B-NP O
days NNS I-NP O
Insulin NNP B-NP O
REGULAR NNP I-NP O
HUMAN NNP I-NP O
3 CD I-NP O
UNITS NNP I-NP O
SC NNP I-NP O
AC+HS NNP I-NP O
, , O O
use NN B-NP O
per IN B-PP O
sliding VBG B-VP O
scale-2U JJ B-ADJP O
if IN B-PP O
150-200 CD B-NP O
, , O O
4U IN B-ADVP O
if IN B-PP O
200-250 CD B-NP O
, , O O
6U JJ B-ADJP O
250-300 CD B-NP O
, , O O
8U CD B-NP O
300-350 CD I-NP O
Protonix NNP B-NP O
( -LRB- I-NP O
PANTOPRAZOLE NN I-NP O
) -RRB- I-NP O
40MG . I-NP O
TABLET NNP I-NP O
EC NNP I-NP O
take VBP B-VP O
1 CD B-NP O
Tablet( NN I-NP O
s VBZ B-VP O
) -RRB- B-NP O
PO NN I-NP O
QD . O O
Trazodone DT B-NP O
50MG JJ I-NP O
TABLET NNP I-NP O
take NN I-NP O
1 CD B-NP O
Tablet( NN I-NP O
s VBZ B-VP O
) -RRB- B-NP O
PO NN I-NP O
qhs NNS I-NP O
PRN NNP B-NP O
insomna . O O
Naprosyn NNP B-NP O
( -LRB- I-NP O
NAPROXEN NNP I-NP O
) -RRB- I-NP O
500MG . I-NP O
TABLET NNP I-NP O
take VB B-VP O
1 CD B-NP O
Tablet( NN I-NP O
s VBZ B-VP O
) -RRB- B-NP O
PO NN I-NP O
BID . O O
Polytrim NN B-NP O
( -LRB- I-NP O
TRIMETHOPRIM/POLYMYXIN NNP I-NP O
B NNP I-NP O
SULFATE NNP I-NP O
) -RRB- I-NP O
1 CD I-NP O
DROP NNP I-NP O
OU NNP I-NP O
Q4-6H NNP I-NP O
x NN I-NP O
7 CD B-NP O
days NNS I-NP O
Proventil NN B-NP O
INH NNP I-NP O
2 CD I-NP O
PUFFS NNP I-NP O
INH NNP I-NP O
Q NNP I-NP O
6 CD I-NP O
H NNP I-NP O
PRN NNP I-NP O
SOB NNP I-NP O
, , O O
PRN NNP B-NP O
: : O O
SOB/WHEEZING VBG B-SBAR O
Azmacort NNP B-NP O
INH NNP I-NP O
2 CD I-NP O
PUFF NNP I-NP O
AER NNP I-NP O
BID NNP I-NP O
Glucophage NNP B-NP O
500 CD I-NP O
MG NNP I-NP O
PO NNP I-NP O
BID NNP I-NP O
Lipitor NNP B-NP O
40 CD I-NP O
MG NNP I-NP O
PO NNP I-NP O
QD . O O
Zestoretic NNP B-NP O
( -LRB- I-NP O
LISINOPRIL/HYDROCHLOROTHIAZIDE NNP I-NP O
) -RRB- I-NP O
20-25 CC I-NP O
TABLET NNP I-NP O
take VBP B-VP O
1 CD B-NP O
Tablet( NN I-NP O
s VBZ B-VP O
) -RRB- B-NP O
PO NN I-NP O
QD . O O
Ecasa NNP B-NP O
( -LRB- I-NP O
ASPIRIN NNP I-NP O
ENTERIC NNP I-NP O
COATED NNP I-NP O
) -RRB- I-NP O
325MG JJ I-NP O
TABLET NNP I-NP O
EC NNP I-NP O
take VBP B-VP O
1 CD B-NP O
Tablet( NN I-NP O
s VBZ B-VP O
) -RRB- B-NP O
PO NN I-NP O
QD . O O
Clarinex NNP B-NP O
( -LRB- I-NP O
DESLORATADINE NNP I-NP O
) -RRB- I-NP O
5MG VBP I-NP O
TABLET NNP I-NP O
take VB B-VP O
1 CD B-NP O
Tablet( NN I-NP O
s VBZ B-VP O
) -RRB- B-NP O
PO NN I-NP O
QD . O O
Plavix NNP B-NP O
( -LRB- I-NP O
CLOPIDOGREL NN I-NP O
) -RRB- I-NP O
75 CD I-NP O
MG NNP I-NP O
PO NNP I-NP O
QD . O O
Paxil NNP B-NP O
( -LRB- I-NP O
PAROXETINE NN B-NP O
) -RRB- I-NP O
20 CD I-NP O
MG NNP I-NP O
( -LRB- I-NP O
20MG JJ I-NP O
TABLET NNP I-NP O
take NN I-NP O
1 CD B-NP O
) -RRB- I-NP O
PO NN I-NP O
QD . O O
Atenolol IN B-PP O
50 CD B-NP O
MG NN I-NP O
( -LRB- I-NP O
50MG JJ I-NP O
TABLET NNP I-NP O
take NN I-NP O
1 CD B-NP O
) -RRB- I-NP O
PO NN I-NP O
QD . O O
Flucoconzole NNP B-NP O
150 CD I-NP O
MG NNP I-NP O
PO NNP I-NP O
x1 NNP I-NP O
x NN I-NP O
1 CD B-NP O
day NN I-NP O
Lotrimin NNP B-NP O
1 CD I-NP O
% NN I-NP O
CREAM NNP I-NP O
( -LRB- I-NP O
CLOTRIMAZOLE NN I-NP O
1 CD I-NP O
% NN I-NP O
CREAM NN I-NP O
) -RRB- I-NP O
1 CD I-NP O
APPLICATION NN I-NP O
TOP NNP I-NP O
QD NNP I-NP O
, , O O
apply VB B-VP O
to TO B-PP O
vaginal JJ B-NP O
area NN I-NP O
( -LRB- B-VP O
external JJ B-NP O
) -RRB- I-NP O
qd JJ I-NP O
prn NN I-NP O
itch NN I-NP O
Insulin NNP B-NP O
70/30 CD I-NP O
( -LRB- I-NP O
HUMAN NNP B-PP O
) -RRB- B-NP O
30 CD I-NP O
U/30 IN B-PP O
U NNP B-NP O
SC NNP I-NP O
QAM/Qpm . O O
. . O O
. . O O
of IN B-PP O
note NN B-NP O
, , O O
pt NN B-NP O
is VBZ B-VP O
not RB I-VP O
taking VBG I-VP O
any DT B-NP O
of IN B-PP O
her PRP$ B-NP O
medications NNS I-NP O
. . O O
EXAM NNP B-NP O
: : O O
Vital JJ B-NP O
Signs NNS I-NP O
BP NNP B-NP O
170/86 CD I-NP O
, , O O
P NNP B-NP O
86 CD I-NP O
, , O O
Wt NNP B-NP O
154 CD I-NP O
lb NN I-NP O
Neck NNP B-NP O
No DT B-NP O
JVD NNP I-NP O
No NNP I-NP O
thyromegaly . O O
Cor NNP B-NP O
RRR NNP I-NP O
, , O O
S1S2 NNP B-NP O
, , O O
2/6 CD B-NP O
sys NNS I-NP O
M NNP B-NP O
at IN B-PP O
RUSB NNP B-NP O
Lungs NNP B-NP O
CTA NNP I-NP O
bl NN I-NP O
, , O O
no DT B-NP O
crackles/wheezes NNS I-NP O
Abd NNP B-NP O
Soft NNP I-NP O
NTND NNP I-NP O
+BS . O O
Ext JJ B-NP O
No DT I-NP O
c/c/e NN I-NP O
NEURO NNP B-NP O
: : O O
PERRL. NNP B-NP O
Facial NNP I-NP O
asymmetry NN I-NP O
, , O O
unable JJ B-ADJP O
to TO B-VP O
smile VB I-VP O
or CC I-VP O
raise VB I-VP O
eyebrow NN B-NP O
on IN B-PP O
L, NNP B-NP O
tongue NN I-NP O
deviates NNS I-NP O
to TO B-PP O
R. NNP B-NP O
Strength NNP I-NP O
4/5 VBD B-VP O
LUE NNP B-NP O
extensors NNS I-NP O
, , O O
o/w JJ B-NP O
5/5 CD I-NP O
throughout IN I-NP O
. . O O
Loss NN B-NP O
of IN B-PP O
sensation NN B-NP O
Normal JJ B-NP O
gait NN I-NP O
. . O O
Unchanged JJ B-ADJP O
fr IN B-PP O
previous JJ B-NP O
Results NNS B-NP O
Date/Time NNP B-NP O
NA NNP I-NP O
K NNP I-NP O
CL NN I-NP O
CO2 . O O
05/08/2066 CD B-NP B-DATE
4.2 CD I-NP O
05/06/2066 CD B-NP B-DATE
134 CD I-NP O
( -LRB- I-NP O
* NN I-NP O
) -RRB- O O
4.2 CD B-NP O
97 CD I-NP O
( -LRB- O O
* NN B-NP O
) -RRB- I-NP O
28 CD O O
05/01/2066 CD B-NP B-DATE
137 CD I-NP O
3.4 CD I-NP O
( -LRB- I-NP O
* NN I-NP O
) -RRB- I-NP O
96 CD I-NP O
( -LRB- I-NP O
* NN I-NP O
) -RRB- O O
33 CD B-NP O
( -LRB- I-NP O
* NN I-NP O
) -RRB- O O
Date/Time NNP B-NP O
BUN NNP I-NP O
CRE NNP I-NP O
GLU NNP I-NP O
ANION NN I-NP O
05/08/2066 CD B-NP B-DATE
0.9 CD I-NP O
05/06/2066 CD B-NP B-DATE
13 CD I-NP O
0.7 CD I-NP O
285 CD I-NP O
( -LRB- I-NP O
* NN I-NP O
) -RRB- I-NP O
9 CD O O
05/01/2066 CD B-NP B-DATE
19 CD I-NP O
0.8 CD I-NP O
187 CD I-NP O
( -LRB- I-NP O
* NN I-NP O
) -RRB- O O
8 CD O O
Date/Time NNP B-NP O
CA NNP I-NP O
TBILI NNP I-NP O
TP NNP I-NP O
ALB NNP I-NP O
05/06/2066 CD B-NP B-DATE
9.6 CD I-NP O
05/01/2066 CD B-NP B-DATE
9.5 CD I-NP O
0.3 CD I-NP O
7.2 CD I-NP O
3.8 CD O O
Date/Time NNP B-NP O
GLOB NNP I-NP O
05/01/2066 CD B-NP B-DATE
3.4 CD I-NP O
Date/Time NNP B-NP O
ALT/SGPT NNP I-NP O
AST/SGOT NNP I-NP O
ALKP NNP I-NP O
TBILI . O O
05/01/2066 CD B-NP B-DATE
15 CD I-NP O
16 CD I-NP O
89 CD I-NP O
0.3 CD O O
Date/Time NNP B-NP O
CHOL NNP I-NP O
TRIG NNP I-NP O
HDL NNP I-NP O
LDLCAL NNP I-NP O
05/08/2066 CD B-NP B-DATE
272 CD I-NP O
( -LRB- I-NP O
* NN I-NP O
) -RRB- I-NP O
301 CD I-NP O
( -LRB- I-NP O
* NN I-NP O
) -RRB- I-NP O
46 CD I-NP O
166 CD I-NP O
( -LRB- B-PP O
* NN B-NP O
) -RRB- O O
Date/Time NNP B-NP O
VLDL NNP I-NP O
05/08/2066 CD B-NP B-DATE
60 CD I-NP O
Date/Time NNP B-NP O
MALB NNP I-NP O
MALB/CRE NNP I-NP O
05/08/2066 CD B-NP B-DATE
9.8 CD I-NP O
( -LRB- I-NP O
* NN I-NP O
) -RRB- I-NP O
59.8 CD I-NP O
( -LRB- I-NP O
*)[ NN I-NP O
1 CD B-NP O
] NN I-NP O
Date/Time NNP B-NP O
UTIME NN I-NP O
05/08/2066 CD B-NP B-DATE
RANDOM NN I-NP O
Date/Time NNP B-NP O
UTIME NNP I-NP O
U/UCRE . O O
05/08/2066 CD B-NP B-DATE
RANDOM NNP I-NP O
163.9 CD I-NP O
Date/Time NNP B-NP O
WBC NNP I-NP O
RBC NNP I-NP O
HGB NNP I-NP O
HCT . O O
05/01/2066 CD B-NP B-DATE
10.40 CD I-NP O
( -LRB- I-NP O
* NN I-NP O
) -RRB- B-PP O
4.29 CD B-NP O
13.3 CD I-NP O
37.6 CD O O
Date/Time NNP B-NP O
MCV NNP I-NP O
MCH NNP I-NP O
MCHC NNP I-NP O
PLT . O O
05/01/2066 CD B-NP B-DATE
87.6 CD I-NP O
31.1 CD I-NP O
35.5 CD I-NP O
302 CD O O
Date/Time NNP B-NP O
RDW NNP I-NP O
05/01/2066 CD B-NP B-DATE
12.4 CD I-NP O
Date/Time NNP B-NP O
%POLY-A NNP I-NP O
%LYMPH-A NNP I-NP O
%MONO-A NNP I-NP O
%EOS-A . O O
05/01/2066 CD B-NP B-DATE
65.5 CD I-NP O
29 CD I-NP O
4.2 CD I-NP O
( -LRB- B-PP O
# # B-NP O
) -RRB- I-NP O
0.9 CD O O
Date/Time NNP B-NP O
%BASO-A NNP I-NP O
05/01/2066 CD B-NP B-DATE
0.4 CD I-NP O
Date/Time NNP B-NP O
ANEUT-A NNP I-NP O
ALYMP-A NNP I-NP O
AMONO-A NNP I-NP O
AEOS-A NNP I-NP O
05/01/2066 CD B-NP B-DATE
6.81 CD I-NP O
3.01 CD I-NP O
0.44 CD I-NP O
0.09 CD O O
Date/Time NNP B-NP O
ABASO-A NNP I-NP O
05/01/2066 CD B-NP B-DATE
0.04 CD I-NP O
[1 CD B-NP O
] NN I-NP O
RESULT NNP I-NP O
COMMENT NNP I-NP O
: : O O
Units NNS B-NP O
= SYM B-VP O
mg JJ B-NP O
Alb/g NNP I-NP O
Cre NNP I-NP O
A/P NNP B-NP O
: : O O
53 CD B-NP B-AGE
F NNP I-NP O
with IN B-PP O
MMP NNP B-NP O
incl IN B-PP O
DM NNP B-NP O
, , O O
high JJ B-NP O
chol NN I-NP O
, , O O
depression NN B-NP O
, , O O
s/p JJ B-NP O
TIA NNP I-NP O
, , O O
noncompliance NN B-NP O
, , O O
for IN B-PP O
f/u NN B-NP O
1 CD B-NP O
) -RRB- I-NP O
Recent JJ I-NP O
possible JJ I-NP O
HIV NN I-NP O
exposure NN I-NP O
: : O O
Neg NNP B-NP O
HIV NNP I-NP O
and CC O O
other JJ B-NP O
STDs NNS I-NP O
, , O O
pt NN B-NP O
did VBD B-VP O
not RB I-VP O
return VB I-VP O
for IN B-PP O
recheck NN B-NP O
6 CD I-NP O
mos NN I-NP O
after IN B-PP O
exposure NN B-NP O
in IN B-PP O
12/65 CD B-NP B-DATE
, , O O
pt RB B-ADVP O
will MD B-VP O
think VB I-VP O
about IN B-PP O
re NN B-NP O
testing NN I-NP O
adn NN I-NP O
decide VBP B-VP O
at IN B-PP O
next JJ B-NP O
visit NN I-NP O
2 CD B-NP O
) -RRB- I-NP O
DM NNP I-NP O
: : O O
Humulin NNP B-NP O
70/30 CD B-NP O
at IN B-PP O
70qam NNP B-NP O
and CC O O
30 CD B-NP O
qpm NN I-NP O
after IN B-PP O
off RB B-NP O
for IN B-PP O
several JJ B-NP O
mos NN I-NP O
. . O O
Last JJ B-NP O
A1c NNP I-NP O
was VBD B-VP O
13.9 CD B-NP O
. . B-PP O
5/23 CD B-NP B-DATE
, , O O
-- : O O
see VBP B-VP O
B. NNP B-NP B-DOCTOR
Jamieson NNP I-NP I-DOCTOR
for IN B-PP O
insulin NN B-NP O
titration NN I-NP O
. . O O
--Cont JJ B-NP O
glucophage NN I-NP O
500 CD B-NP O
bid NN I-NP O
--cont JJ B-NP O
ASA NNP I-NP O
, , O O
statin NN B-NP O
--referred JJ B-NP O
to TO B-VP O
opthamology NN I-VP O
3)NEURO-s/p JJ B-NP O
CVA NNP I-NP O
, , O O
needs VBZ B-VP O
to TO B-VP O
f/u VB I-VP O
with IN B-PP O
neuro NN B-NP O
given VBN I-NP O
this DT B-NP O
light NN I-NP O
headedness NN I-NP O
she PRP B-NP O
feels VBZ B-VP O
, , O O
which WDT B-NP O
she PRP B-NP O
thinks VBZ B-VP O
is VBZ B-VP O
how WRB B-ADVP O
she PRP B-NP O
felt VBD B-VP O
before IN B-PP O
the DT B-NP O
last JJ I-NP O
CVA NNP I-NP O
. . I-NP O
ASA NNP I-NP O
325 CD I-NP O
qd JJ I-NP O
,will NN I-NP O
refer VBP B-VP O
to TO B-PP O
Neurology NNP B-NP O
at IN B-PP O
next JJ B-NP O
visit NN I-NP O
. . O O
4)CV-Recent JJ B-NP O
stress NN I-NP O
echo VBP B-VP O
with IN B-PP O
low JJ B-NP O
sensitivity NN I-NP O
given VBN B-NP O
poor JJ I-NP O
exercise NN I-NP O
tolerance NN I-NP O
but CC O O
nondiagnostic JJ B-ADJP O
of IN B-PP O
ischemia NN B-NP O
. . O O
HTN '' O O
poorly RB B-NP O
controlled VBN I-NP O
likely JJ I-NP O
bc NN I-NP O
pt VBD B-VP O
not RB O O
compliant JJ B-ADJP O
with IN B-PP O
meds NNS B-NP O
. . O O
. . O O
- : O O
Will MD B-VP O
schedule VB I-VP O
MIBI NNP B-NP O
again RB B-ADVP O
. . O O
--BP JJ B-NP O
elevated VBD I-NP O
: : O O
Atenolol IN B-NP O
50 CD I-NP O
Cont JJ I-NP O
Zestoretic NNP I-NP O
. . O O
Will MD B-VP O
see VB I-VP O
NP NNP B-NP O
in IN B-PP O
1 CD B-NP O
wk NN I-NP O
and CC O O
may MD B-VP O
need VB I-VP O
further JJ B-NP O
incr NN I-NP O
in IN B-PP O
Atenolol NNP B-NP O
(used VBD B-VP O
to TO I-VP O
be VB I-VP O
on IN B-PP O
100 CD B-NP O
) -RRB- O O
--Cont JJ B-NP O
Lipitor NNP I-NP O
40 CD I-NP O
mg NN I-NP O
qd NN I-NP O
, , O O
Lipids NNS B-NP O
continue VBP B-VP O
to TO I-VP O
be VB I-VP O
elevated VBN I-VP O
, , O O
will MD B-VP O
recheck VB I-VP O
in IN B-PP O
3 CD B-NP O
months NNS I-NP O
--Cont JJ B-NP O
ASA NNP I-NP O
325 CD I-NP O
qd . O O
5)PSYCH-Depression JJ B-NP O
, , O O
doing VBG B-VP O
well RB B-ADVP O
fr IN B-PP O
this DT B-NP O
. . O O
Cont NNP O O
Celexa NNP O O
to TO B-PP O
40 CD B-NP O
qd NN I-NP O
6)PULM-Asthma DT B-NP O
. . I-NP O
Cont NNP I-NP O
albuterol NN I-NP O
and CC I-NP O
asthmacort NN I-NP O
7)GI-GERD. DT B-NP O
Cont NNP I-NP O
Protonix NNP I-NP O
8) JJ B-NP O
Heme NNP I-NP O
: : O O
Hct NNP B-NP O
37 CD I-NP O
and CC O O
MCV NNP B-NP O
9)Vaginal JJ B-NP O
candidiasis NN I-NP O
: : O O
Diflucan NNP B-NP O
150 CD I-NP O
x1 CD O O
Cream NN B-NP O
10) CD B-NP O
Health NNP I-NP O
Maint NNP I-NP O
: : O O
--Overdue JJ B-ADJP O
for IN B-PP O
Mammo NNP B-NP O
( -LRB- I-NP O
last JJ B-NP O
3 CD I-NP O
yrs NNS I-NP O
ago RB B-ADVP O
) -RRB- B-VP O
, , O O
scheduled VBN B-UCP O
--Will DT B-NP O
schedule NN I-NP O
colonoscopy NN I-NP O
at IN B-PP O
next JJ B-NP O
visit NN I-NP O
11)F/u CD B-NP O
in IN B-PP O
2 CD B-NP O
weeks NNS I-NP O
referred VBN B-VP O
to TO B-PP O
Social NNP B-NP O
work VB B-VP O
for IN B-PP O
assistance NN B-NP O
with IN B-PP O
compliance NN B-NP O
. . O O
Discussed VBN B-VP O
with IN B-PP O
Dr NNP B-NP O
Blanchard NNP I-NP B-DOCTOR
Hope NNP B-NP B-DOCTOR
Roberts NNP I-NP I-DOCTOR
, , O O
MD NNP B-NP O
== NN B-NP O
= SYM O O
= SYM O O
= SYM O O
= SYM O O
= SYM O O
= SYM O O
= SYM O O
= SYM O O
= SYM O O
= SYM O O
= SYM O O
= SYM O O
= SYM O O
= SYM O O
= SYM O O
= SYM O O
= SYM O O
= SYM O O
= SYM O O
= SYM O O
= SYM O O
= SYM O O
= SYM O O
= SYM O O
Preceptor NNP B-NP O
's POS B-NP O
Note NNP I-NP O
== NNP I-NP O
= SYM O O
= SYM O O
= SYM O O
= SYM O O
= SYM O O
= SYM O O
= SYM O O
= SYM O O
= SYM O O
= SYM O O
= SYM O O
= SYM O O
= SYM O O
= SYM O O
= SYM O O
= SYM O O
= SYM O O
= SYM O O
= SYM O O
= SYM O O
= SYM O O
= SYM O O
= SYM O O
= SYM O O
51 CD B-NP B-AGE
yo NNP I-NP O
woman NN I-NP O
with IN B-PP O
HTN NNP B-NP O
, , O O
DM NNP B-NP O
, , O O
CAD NNP B-NP O
, , O O
gastritis NN B-NP O
, , O O
depression NN B-NP O
, , O O
s/p VBD B-VP O
CVA NNP B-NP O
, , O O
noncompliance NN B-NP O
for IN B-PP O
f/u NN B-NP O
. . O O
Ran VBD B-VP O
out IN B-PP O
of IN B-PP O
medications NNS B-NP O
1 CD B-NP O
month NN I-NP O
ago RB B-ADVP O
, , O O
sugars NNS B-NP O
in IN B-PP O
500s NNS B-NP O
. . O O
C/o NN B-VP O
dysuria/vaginal JJ B-NP O
itching NN I-NP O
. . O O
Had VBD B-VP O
stress NN B-NP O
test NN I-NP O
in IN B-PP O
2065 CD B-NP B-DATE
that DT B-NP O
was VBD B-VP O
c/w JJ B-ADJP O
but CC O O
not RB B-ADJP O
dx JJ I-ADJP O
ischemia NN B-NP O
, , O O
did VBD B-VP O
n't RB I-VP O
f/u VB I-VP O
for IN B-PP O
MIBI. NNP B-NP O
BP NNP I-NP O
170/86 CD I-NP O
. . O O
LDL NNP B-NP O
166 CD I-NP O
. . O O
Last JJ B-NP O
a1c JJ I-NP O
13 CD I-NP O
. . O O
Plan NNP O O
. . B-NP O
Will NNP I-NP O
restart NN I-NP O
all DT B-NP O
medications NNS I-NP O
. . O O
Had VBD B-VP O
HIV NNP B-NP O
exposure NN I-NP O
and CC O O
one CD B-NP O
test NN I-NP O
but CC B-NP O
not RB I-NP O
a DT B-NP O
f/u NN I-NP O
test NN I-NP O
. . O O
F/u '' O O
in IN B-PP O
2 CD B-NP O
weeks NNS I-NP O
to TO B-VP O
assess VB I-VP O
medication NN B-NP O
compliance NN I-NP O
and CC O O
check NN B-NP O
BP. NNP I-NP O
D/w NNP I-NP O
Dr. NNP I-NP O
Roberts NNP I-NP B-DOCTOR
. . I-NP O
Blanchard NNP I-NP B-DOCTOR
,MD . O O
